miR‐29 suppression of osteonectin in osteoblasts: Regulation during differentiation and by canonical Wnt signaling
Top Cited Papers
- 29 June 2009
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 108 (1) , 216-224
- https://doi.org/10.1002/jcb.22243
Abstract
The matricellular protein osteonectin, secreted protein acidic and rich in cysteine (SPARC, BM‐40), is the most abundant non‐collagenous matrix protein in bone. Matricellular proteins play a fundamental role in the skeleton as regulators of bone remodeling. In the skeleton, osteonectin is essential for the maintenance of bone mass and for balancing bone formation and resorption in response to parathyroid hormone (PTH). It promotes osteoblast differentiation and cell survival. Mechanisms regulating the expression of osteonectin in the skeleton and in other tissues remain poorly understood. We found that the proximal region of the mouse osteonectin 3′ untranslated region (UTR) contains a well‐conserved, dominant regulatory motif that interacts with microRNAs (miRs)‐29a and ‐29c. Transfection of osteoblastic cells with miR‐29a inhibitors increased osteonectin protein levels, whereas transfection of miR‐29a precursor RNA decreased osteonectin. miR‐29a and ‐29c were increased during osteoblastic differentiation in vitro. The up‐regulation of these miRNAs correlated with decreased osteonectin protein during the matrix maturation and mineralization phases of late differentiation. In contrast, osteonectin transcript levels remained relatively constant during this process, implying repression of translation. Treatment of osteoblasts with LiCl induced miR‐29a and ‐29c expression and decreased osteonectin synthesis. When cells were treated with Dickkopf‐1 (Dkk‐1), miR‐29a and ‐29c expression was repressed. These data suggest that canonical Wnt signaling, which is increased during osteoblastic differentiation, induces expression of miR‐29. Osteonectin and miR‐29 are co‐expressed in extra‐skeletal tissues, and the post‐transcriptional mechanisms regulating osteonectin in osteoblasts are likely to be active in other cell systems. J. Cell. Biochem. 108: 216–224, 2009.Keywords
This publication has 45 references indexed in Scilit:
- β-Catenin Levels Influence Rapid Mechanical Responses in OsteoblastsJournal of Biological Chemistry, 2008
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences, 2008
- Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null miceBone, 2008
- The Copper Binding Domain of SPARC Mediates Cell Survival in Vitro via Interaction with Integrin β1 and Activation of Integrin-linked KinasePublished by Elsevier ,2008
- MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteinsProceedings of the National Academy of Sciences, 2008
- Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosisOsteoporosis International, 2007
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed PairingPublished by Elsevier ,2007
- Illuminating the silence: understanding the structure and function of small RNAsNature Reviews Molecular Cell Biology, 2007
- Prediction of Mammalian MicroRNA TargetsCell, 2003